• 1
    Stergiou L., Hengartner M.O., Death and more: DNA damage response pathways in the nematode C. elegans Cell Death Differ., 11: 2128, 2004.
  • 2
    Black R.A., Kronheim S.R., Merriam J.E., March C.J., Hopp T.P., A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta, J. Biol. Chem., 264: 53235326, 1989.
  • 3
    Wolf B.B., Green D.R., Suicidal tendencies: apoptotic cell death by caspase family proteinases, J. Biol. Chem., 274: 2004920052, 1999.
  • 4
    Johnson D.E., Noncaspase proteases in apoptosis, Leukemia, 14: 16951703, 2000.
  • 5
    French L.E., Tschopp J., Protein-based therapeutic approaches targeting death receptors, Cell Death Differ., 10: 117123, 2003.
  • 6
    Ferri K.F., Kroemer G., Organelle-specific initiation of cell death pathways, Nat. Cell Biol., 3:E255263, 2001.
  • 7
    Norbury C.J., Zhivotovsky B., DNA damage-induced apoptosis, Oncogene, 23: 27972808, 2004.
  • 8
    Cory S., Huang D.C., Adams J.M., The Bcl-2 family: roles in cell survival and oncogenesis, Oncogene, 22: 85908607, 2003.
  • 9
    Guo Y., Srinivasula S.M., Druilhe A., Fernandes-Alnemri T., Alnemri E.S., Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria, J. Biol. Chem. 277: 1343013437, 2002.
  • 10
    Tinel A., Tschopp J., The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress, Science, 304: 843846, 2004.
  • 11
    Chang D.W., Ditsworth D., Liu H., Srinivasula S.M., Alnemri E.S., Yang X., Oligomerization is a general mechanism for the activation of apoptosis initiator and inflammatory procaspases, J. Biol. Chem. 278: 1646616469, 2003.
  • 12
    Rao R.V., Ellerby H.M., Bredesen D.E., Coupling endoplasmic reticulum stress to the cell death program, Cell Death Differ., 11: 372380, 2004.
  • 13
    Mancini M., Machamer C.E., Roy S., Nicholson D.W., Thornberry N.A., Casciola-Rosen L.A., Rosen A., Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis, J. Cell Biol. 149: 603612, 2000.
  • 14
    Guicciardi M.E., Leist M., Gores G.J., Lysosomes in cell death, Oncogene, 23: 28812890, 2004.
  • 15
    Liston P., Fong W.G., Korneluk R.G., The inhibitors of apoptosis: there is more to life than Bcl2, Oncogene, 22: 85688580, 2003.
  • 16
    Roth W., Kermer P., Krajewska M., Welsh K., Davis S., Krajewski S., Reed J.C., Bifunctional apoptosis inhibitor (BAR) protects neurons from diverse cell death pathways, Cell Death Differ., 10: 11781187, 2003.
  • 17
    Saelens X., Festjens N., Walle L.V., van Gurp M., van Loo G., Vandenabeele P., Toxic proteins released from mitochondria in cell death, Oncogene, 23: 28612874, 2004.
  • 18
    Jia L., Patwari Y., Kelsey S.M., Srinivasula S.M., Agrawal S.G., Alnemri E.S., Newland A.C., Role of Smac in human leukaemic cell apoptosis and proliferation, Oncogene, 22: 15891599, 2003.
  • 19
    Martins L.M., Iaccarino I., Tenev T., Gschmeissner S., Totty N.F., Lemoine N.R., Savopoulos J., Gray C.W., Creasy C.L., Dingwall C., Downward J., The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif, J. Biol. Chem., 277: 439444, 2002.
  • 20
    Fadeel B., Orrenius S., Zhivotovsky B., Apoptosis in human disease: a new skin for the old ceremony?, Biochem. Biophys. Res. Commun., 266: 699717, 1999.
  • 21
    Brunner T., Mueller C., Apoptosis in disease: about shortage and excess, Essays Biochem., 39: 119130, 2003.
  • 22
    Kreuter M., Langer C., Kerkhoff C., Reddanna P., Kania A.L., Maddika S., Chlichlia K., Bui T.N., Los M., Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development, Arch. Immunol. Ther. Exp., 52: 141155, 2004.
  • 23
    Hayakawa Y., Chandra M., Miao W., Shirani J., Brown J.H., Dorn G.W. 2nd, Armstrong R.C., Kitsis R.N., Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice, Circulation 108: 30363041, 2003.
  • 24
    Hoglen N.C., Chen L.S., Fisher C.D., Hirakawa B.P., Groessl T., Contreras P.C., Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor, J. Pharmacol. Exp. Ther., 309: 634640, 2004.
  • 25
    Kawasaki M., Kuwano K., Hagimoto N., Matsuba T., Kunitake R., Tanaka T., Maeyama T., Hara N., Protection from lethal apoptosis in lipopolysaccharideinduced acute lung injury in mice by a caspase inhibitor, Am. J. Pathol., 157: 597603, 2000.
  • 26
    Yang B., Johnson T.S., Haylor J.L., Wagner B., Watson P.F., El Kossi M.M., Furness P.N., El Nahas A.M., Effects of caspase inhibition on the progression of experimental glomerulonephritis, Kidney Int., 63: 20502064, 2003.
  • 27
    Zhou C., Yamaguchi M., Kusaka G., Schonholz C., Nanda A., Zhang J.H., Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage, J. Cereb. Blood Flow Metab., 24: 419431, 2004.
  • 28
    Chandrashekhar Y., Sen S., Anway R., Shuros A., Anand I., Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction, J. Am. Coll. Cardiol., 43:295301. 2004.
  • 29
    Neviere R., Fauvel H., Chopin C., Formstecher P., Marchetti P., Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis, Am. J. Respir. Crit. Care Med., 163: 218225, 2001.
  • 30
    Yang W., Guastella J., Huang J.C., Wang Y., Zhang L., Xue D., Tran M., Woodward R., Kasibhatla S., Tseng B., Drewe J., Cai S.X., MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity, Br. J. Pharmacol., 140: 402412, 2003.
  • 31
    Zender L., Hutker S., Liedtke C., Tillmann H.L., Zender S., Mundt B., Waltemathe M., Gosling T., Flemming P., Malek N.P., Trautwein C., Manns M.P., Kuhnel F., Kubicka S., Caspase 8 small interfering RNA prevents acute liver failure in mice, Proc. Natl. Acad. Sci. USA, 100: 77977802, 2003.
  • 32
    Roy S., Bayly C.I., Gareau Y., Houtzager V.M., Kargman S., Keen S.L., Rowland K., Seiden I.M., Thornberry N.A., Nicholson D.W., Maintenance of caspase-3 proenzyme dormancy by an intrinsic “safety catch” regulatory tripeptide, Proc. Natl. Acad. Sci. USA, 98: 61326137, 2001.
  • 33
    Buckley C.D., Pilling D., Henriquez N.V., Parsonage G., Threlfall K., Scheel-Toellner D., Simmons D.L., Akbar A.N., Lord J.M., Salmon M., RGD peptides induce apoptosis by direct caspase-3 activation, Nature, 397: 534539, 1999.
  • 34
    Jia L.T., Zhang L.H., Yu C.J., Zhao J., Xu Y.M., Gui J.H., Jin M., Ji Z.L., Wen W.H., Wang C.J., Chen S.Y., Yang A.G., Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3, Cancer Res., 63: 32573262, 2003.
  • 35
    Xu Y.M., Wang L.F., Jia L.T., Qiu X.C., Zhao J., Yu C.J., Zhang R., Zhu F., Wang C.J., Jin B.Q., Chen S.Y., Yang A.G., A caspase-6 and anti-human epidermal growth factor receptor-2 (HER2) antibody chimeric molecule suppresses the growth of HER2-overexpressing tumors, J. Immunol., 173: 6167, 2004.
  • 36
    Tse E., Rabbitts T.H., Intracellular antibody-caspasemediated cell killing: an approach for application in cancer therapy, Proc. Natl. Acad. Sci. USA, 97: 1226612271, 2000.
  • 37
    Philchenkov A., Zavelevich M., Kroczak T.J., Los M., Caspases and cancer: mechanisms of inactivation and new treatment modalities, Exp. Oncol., 26: 8297, 2004.
  • 38
    Yang L., Cao Z., Li F., Post D.E., Van Meir E.G., Zhong H., Wood W.C., Tumor-specific gene expression using the survivin promoter is further increased by hypoxia., Gene Ther., 11: 121523, 2004.
  • 39
    Shariat S.F., Desai S., Song W., Khan T., Zhao J., Nguyen C., Foster B.A., Greenberg N., Spencer D.M., Slawin K.M., Adenovirus-mediated transfer of inducible caspases: a novel “death switch” gene therapeutic approach to prostate cancer, Cancer Res., 61: 25622571, 2001.
  • 40
    Karlsson T., Henriksson R., Hedman H., Induction of apoptosis in resistant glioma cells by synthetic caspaseactivation, J. Neurooncol., 66: 7179, 2004.
  • 41
    Nor J.E., Hu Y., Song W., Spencer D.M., Nunez G., Ablation of microvessels in vivo upon dimerization of iCaspase-9, Gene Ther., 9: 444451, 2002.
  • 42
    Xia C., Xu Z., Yuan X., Uematsu K., You L., Li K., Li L., McCormick F., Jablons D.M., Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides, Mol. Cancer Ther., 1: 687694, 2002.
  • 43
    Hu Y., Cherton-Horvat G., Dragowska V., Baird S., Korneluk R.G., Durkin J.P., Mayer L.D., LaCasse E.C., Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo, Clin. Cancer Res., 9: 28262836, 2003.
  • 44
    Okano H., Shiraki K., Inoue H., Kawakita T., Yamanaka T., Deguchi M., Sugimoto K., Sakai T., Ohmori S., Fujikawa K., Murata K., Nakano T., Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma, Lab. Invest., 83: 103343, 2003.
  • 45
    Williams N.S., Gaynor R.B., Scoggin S., Verma U., Gokaslan T., Simmang C., Fleming J., Tavana D., Frenkel E., Becerra C., Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference, Clin. Cancer Res. 9: 931946, 2003.
  • 46
    Siegmund D., Hadwiger P., Pfizenmaier K., Vornlocher H.P., Wajant H., Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis, Mol. Med., 8: 725732, 2002.
  • 47
    Yang Q.H., Church-Hajduk R., Ren J., Newton M.L., Du C., Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis, Genes Dev., 17: 14871496, 2003.
  • 48
    Pennati M., Binda M., Colella G., Golini M., Citti L., Villa R., Diadone M.G., Zaffaroni N., Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression, J. Invest. Dermatol., 120: 648654, 2003.
  • 49
    Yanamandra N., Kondraganti S., Srinivasula S.M., Gujrati M., Olivero W.C., Dinch D.H., Rao J.S., Activation of caspase-9 with irradiation inhibits invasion and angiogenesis in SNB19 human glioma cells, Oncogene, 23: 23392346, 2004.
  • 50
    Ansell S.M., Arendt B.K., Grote D.M., Jelinek D.F., Novak A.J., Wellik L.E., Remstein E.D., Bennett C.F., Fielding A., Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma, Leukemia, 18: 616623, 2004.
  • 51
    Takeuchi H., Kanzawa T., Kondo Y., Komata T., Hirohata S., Kyo S., Kondo S., Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells, Int. J. Oncol., 25: 5763, 2004.
  • 52
    Los M., Stroh C., Janicke R.U., Engels I.H., Schulze Osthoff K., Caspases: more than just killers?, Trends Immunol., 22: 3134, 2001.
  • 53
    Philchenkov A.A., Caspases as regulators of apoptosis and other cell functions, Biochemistry (Mosc), 68: 365376, 2003.